Our investment approach combines direct investments in early-stage companies with venture creation from bold ideas in global innovation hubs

Our goal is to enable talented entrepreneurs to scale more quickly and effectively through access to our capital, enterprise capabilities and consumer touchpoints, while offering expertise and insights from Angelini’s unique perspective.

We invest primarily across Europe and North America, recognizing that healthcare technology innovation is occurring in many cities around the world.

We have committed €300M for investments and company creation in Digital Health and BioTech.



We partner with entrepreneurs through the entire journey of company building, investing from Seed to Series A. We engage with entrepreneurs early in their journey, but we invest for the long term.

Venture Capital Community

We are active in the venture capital ecosystem and have forged partnerships with top investors in Europe and North America. This expands our investment reach.

Research and Academic Institutions

We partner with the investment community and top experts in tech transfer to identify the transformative ideas that will become the most valuable companies.